Molecular Characterization of Acquired Resistance to the BRAF Inhibitor Dabrafenib in a Patient with BRAF-Mutant Non–Small-Cell Lung Cancer - Concepedia

Concepedia

Publication | Open Access

Molecular Characterization of Acquired Resistance to the BRAF Inhibitor Dabrafenib in a Patient with BRAF-Mutant Non–Small-Cell Lung Cancer

DOI Full Paper Access

103

Citations

4

References

2013

Year

Charles M. Rudin, Kelvin Hong, Michael Streit

Journal of Thoracic Oncology

Tumor BiologyMolecular CharacterizationOncologyAcquired ResistanceMedicineCancer Cell BiologyPathologyCancer TreatmentCancer GeneticsPharmacologyLung CancerMolecular OncologyBraf Inhibitor Dabrafenib

References

	Year	Citations

Page 1